This video shows a uniportal VATS left lower lobectomy. The dissection was performed down to up, and an aberrant vein was incidentally found.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
July 15, 2016
This is a retrospective National Cancer Data Base cohort study of patients with pathologic stage T3 invasive NSCLC with separate tumor nodules in the same lobe. The goal was to determine with adjuvant chemotherapy increased survival.
June 30, 2016
The multi-institutional prospective study evaluated the behavior of pure GGOs (85%), heterogeneous GGOs (part solid only on CT lung windows; 7%), and part-solid GGOs on soft-tissue windows. Among pure GGOs, 6.6% advanced to one of the other categories during a mean follow-up period of 4.3 years. Of the 35 pure GGOs that were resected, none was an
June 28, 2016
This video shows a uniportal subxiphoid lobectomy in a patient with a proven adenocarcinoma of the middle lobe.
June 11, 2016
The authors summarize findings in a single institution retrospective review of patients undergoing pre-discharge VTE screening after pneumonectomy for NSCLC and compare outcomes to an historic series of patients who did not have screening. Rates of VTE in the screened group were 8.9% at discharge, an additional 3.4% within 30 days postop, and 5.4% &
June 11, 2016
The author describes the growing role of SBRT in lung cancer therapy and the growing role of radiation oncologists in decision-making regarding lung cancer. The cautionary note is that surgeons need to remain actively involved in staging, patient assessment, and treatment recommendations.
Commentary:
June 7, 2016
This video demonstrates the surgical treatment of a 57-year-old patient with a neuroendocrine tumor in the apical segment of the right upper lobe.
June 4, 2016
The authors used data from the NCDB to assess long-term outcomes after SBRT (1,781) or lobectomy (13,562) for clinical stage I NSCLC in patients without important co-morbidities. Overall survival was significantly better after lobectomy for T1N0 (HR 0.38) and for T2N0 patients (HR 0.38). Propensity score matched patients (1781 pairs) also had signi
May 30, 2016
This video demonstrates the safe control of pulmonary artery bleeding, conversion to VATS lobectomy, and completion of the operation.
May 26, 2016
Michael Snee of St. James’s Institute of Oncology, Leeds, United Kingdom, gives an informative talk on stereotactic ablative radiotherapy (SABR).